000 01347 a2200385 4500
005 20250514225402.0
264 0 _c20050809
008 200508s 0 0 eng d
022 _a0085-2538
024 7 _a10.1111/j.1523-1755.2005.00346.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIbáñez, Luisa
245 0 0 _aCase-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease.
_h[electronic resource]
260 _bKidney international
_cJun 2005
300 _a2393-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnalgesics
_xadverse effects
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadverse effects
650 0 4 _aAspirin
_xadverse effects
650 0 4 _aCase-Control Studies
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOdds Ratio
700 1 _aMorlans, Màrius
700 1 _aVidal, Xavier
700 1 _aMartínez, María José
700 1 _aLaporte, Joan-Ramon
773 0 _tKidney international
_gvol. 67
_gno. 6
_gp. 2393-8
856 4 0 _uhttps://doi.org/10.1111/j.1523-1755.2005.00346.x
_zAvailable from publisher's website
999 _c15545437
_d15545437